Cataldo Bianco
Catanzaro, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules.
Journal: Therapeutic advances in medical oncology
Published: February 13, 2020
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents.
Journal: Journal of clinical medicine
Published: January 29, 2020
Corrigendum to "In vitro permeability of silver nanoparticles through porcine oromucosal membrane" [Colloids Surf. B Biointerfaces 132 (August) (2015) 10-16].
Journal: Colloids and surfaces. B, Biointerfaces
Published: December 10, 2019
Mechanisms of resistance to mTOR inhibitors.
Journal: Critical reviews in oncology/hematology
Published: September 19, 2019
Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities.
Journal: Cancers
Published: July 12, 2019
The Molecular Effects of Ionizing Radiations on Brain Cells: Radiation Necrosis vs. Tumor Recurrence.
Journal: Diagnostics (Basel, Switzerland)
Published: July 08, 2019
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: May 22, 2017
Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report.
Journal: Journal of medical case reports
Published: January 31, 2017
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation.
Journal: Scientific reports
Published: November 21, 2016
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: August 03, 2016
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.
Journal: Oncotarget
Published: December 18, 2015
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.
Journal: Oncotarget
Published: June 04, 2015
Last Updated: 09/26/2026